Advancements in Targeted Cancer Therapies
標靶癌症治療的進展
Advancements in targeted cancer therapy have sparked a revolution in oncology, shifting the focus from broad-spectrum chemotherapy to precision medicine.
標靶癌症治療的進步已在腫瘤學領域引發了一場革命，將重心從廣譜化學治療轉向精準醫學。
Unlike traditional treatments that affect all rapidly dividing cells, targeted therapies specifically identify and disable cancer cells by exploiting their unique genetic or protein-based vulnerabilities.
不同於影響所有快速分裂細胞的傳統療法，標靶治療透過利用癌細胞獨特的遺傳或蛋白質層面的弱點，精確地識別並阻斷癌細胞。
By interfering with critical biological pathways—such as signal transduction or angiogenesis—these therapies effectively 'starve' tumors or force them into programmed cell death.
透過干擾關鍵生物路徑（例如訊息轉導或血管新生），這些療法能有效地「餓死」腫瘤或強迫其進入編程性細胞死亡。
Innovations like antibody-drug conjugates further enhance precision by delivering toxic agents directly to malignant cells.
抗體偶聯藥物等創新技術透過將毒性藥物直接傳送至惡性細胞，進一步提升了精準度。
Nevertheless, the field continues to evolve rapidly.
然而，該領域仍在快速演進。
By targeting specific drivers of cancer, science is turning once-intractable diseases into manageable conditions, drastically improving the quality of life for patients worldwide.
透過針對特定的癌症驅動因子，科學正將過去難以處理的疾病轉化為可控的病況，極大地改善了全球患者的生活品質。
